Analysis Group

Envisioning the Future of Global Supply Chains · Johns Hopkins Sesquicentennial September 17, 2026 Johns Hopkins Carey Business School Washington, DC 12:40–2:10 p.m. (PT) / 3:40–5:10 p.m. (ET) Analysis Group Principal Todd Schatzki will join the “Supply Chains for Artificial Intelligence” panel at Envisioning the Future of Global Supply Chains, a one-day workshop held as part of Johns Hopkins University’s Sesquicentennial celebrations.

August 31, 2026 Health economics and outcomes research (HEOR) has long drawn credibility from its methodological strength and the scientific value associated with it. However, in this contemporary era, expectations for HEOR professionals are becoming more demanding and are increasingly requiring skillsets that expand beyond technical grounding.

August 27, 2026 Biologic therapies can play an important role in managing severe asthma, but patients may encounter barriers to initiating treatment, have difficulty taking their medications consistently, or discontinue therapies over time. Social determinants of health (SDOH) – including education, poverty, housing conditions, internet access, unemployment, and racial or ethnic minority status – may shape patients’ access to and continued use of these treatments.

August 26, 2026 Among patients with metastatic castration-sensitive prostate cancer (mCSPC), undetectable levels (less than 0.2 ng/mL) of absolute prostate-specific antigen (PSA) within nine months of initiating treatment have been associated with improved survival outcomes, as compared to a percentage of PSA decline.

August 26, 2026 Analysis Group was retained on behalf of the radio broadcast company Cumulus Media, the plaintiff in an antitrust lawsuit against The Nielsen Company, a market research firm.

August 25, 2026 Analysis Group was retained by Mayer Brown on behalf of Maxell, a Japanese technology company, in a Section 337 investigation before the US International Trade Commission (ITC). Maxell alleged that Samsung Electronics imported and sold smartphones and tablets that infringed several Maxell patents.

August 24, 2026 The treatment of efficiencies has become one of the central questions raised by the European Commission’s draft guidelines for assessing mergers under the EU Merger Regulation (the Draft Guidelines). The public consultation on the Draft Guidelines closed at the end of June 2026.

August 21, 2026 Thirteen Analysis Group experts and consultants were recognized in Lexology Index’s 2026 Competition – Economists ranking. One expert was named a Global Elite Thought Leader: Managing Principal Antoine Chapsal (France) Four consultants were named Thought Leaders: Principal Emmanuel Frot (France) CEO Pierre Y. Cremieux (USA) Chairman Martha S. Samuelson (USA) Senior Advisor Keith R. Ugone (USA) Three consultants were named Highly Recommended: Senior Advisor Jeffrey A.

42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting August 29–September 2, 2026 International Society for Pharmacoepidemiology (ISPE) Milan, Italy Analysis Group, a global leader in drug safety epidemiology and regulatory RWE, will co-moderate one podium presentation session and present five research posters at the 42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting.

53rd Annual Conference on International Antitrust Law and Policy September 17–18, 2026 Fordham Competition Law Institute New York, NY Analysis Group Managing Principal Aditi Mehta will join the panel Trends in Merger Enforcement: Is International Convergence Still a Goal? on Friday, September 18, 2026, from 2:50 to 4:05 p.m., at Fordham Competition Law Institute’s 53rd Annual Conference on International Antitrust Law and Policy. The panel will be moderated by Ori Schwartz (OECD).